VIMIZIM

Elosulfase alfa · BioMarin Pharmaceutical Inc.

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for VIMIZIM, covering 2014-02-14 to 2025-10-30. Get the full timeline:

Most recent: FDA Approved: VIMIZIM — Supplemental Application (BioMarin Pharmaceutical Inc.)